Bioelectronics and Biosensors Market: Global Industry Analysis and Forecast (2023-2029)

Global Bioelectronics and Biosensors Market size was valued at US$ 29.66 Bn. in 2022 and the total revenue is expected to grow at a CAGR of 9.2% through 2023 to 2029, reaching nearly US$ 54.93 Bn.
Bioelectronics and Biosensors Market Overview:
Electrocardiographs, cardiac pacemakers and defibrillators, blood pressure and flow monitors, and medical imaging systems are all examples of bioelectronics in use. During quality control operations in the food sector, biosensors are used to measure carbohydrates, alcohols, and acids, for example. The gadgets can also be used to monitor fermentation in beer, yoghurt, and soft drinks production. Rapid detection, accuracy, ease of operation, a short response time, and low cost, high sensitivity, and reliability are all requirements for biosensors used in measurement. Based on the type of transducer, biosensors can be divided into electrochemical, optical, piezoelectric, and thermal sensors.To know about the Research Methodology:-Request Free Sample Report
Market Dynamics:
During the forecast period, the rising prevalence of chronic diseases such as heart disease and cancer is expected to drive demand for biosensors around the world. This market is expected to develop because to the higher precision provided by these bioelectronics products when compared to standard diagnostics equipment. During the forecast period, rising awareness of bioelectronics and its applications in implantable devices, biochips, fabrication templates, prosthetics, artificial/bionic organs, biofuel cells, molecular motors, and electrical pills is expected to boost the market growth.

The continual advancements in semiconductor technology, together with developments in surface chemistry and their application to life sciences research, are the overarching technical drivers for bioelectronics. Much of the research in the subject of bioelectronics has concentrated on improving biosensors by combining biomolecules with semiconductors. Moore's law asserts that the number of features in a given area of substrate doubles every 18–24 months, indicating that semiconductor technology has grown at an exponential rate for decades. Moore's law states that with each generation of technology, computing power and capabilities improve as the cost per function lowers.

The number of semiconductor applications in the life sciences has increased as Moore's law has developed. Surface chemistries that can be utilised to attach biological molecules to semiconductor substrates, in particular, have received a lot of attention. Biosensors with enzymes covalently attached to electrode surfaces and DNA recognition using surface-bound DNA functionalized polypyrrole molecules are two examples. Despite breakthroughs in the binding of biological molecules to substrates, no completely biomimetic synthetic surfaces have yet to be developed (e.g., for use in implants). Here are some technical areas or prospects that will have an impact on bioelectronics:

For Systems Biology, Real-Time and Massively Parallel Molecular and Cellular Characterization

The new field of systems biology, which use systems engineering methods to study cellular function, is pushing the development of new technology that can track numerous aspects of cellular behaviour over a long period of time. Systems biology represents a new way of looking at biological systems, and the knowledge gained from its methods could lead to advancements in medicine and security. However, large resources are required to build tools, as well as accompanying standards and metrology that can characterise and continually monitor cell states at sub-cellular resolutions. This demand is being addressed by advances in micro- and Nano fluidic devices that can monitor many cell populations in simultaneously.

Fabrication and biologically-based sensors

Cells and their components can be employed as biological transducers for measurements or as components in the creation of new materials or circuits, which is another driving factor behind bioelectronics. In other words, cell components have been exploited for purposes other than those for which they were designed. Many environmental stimuli are detectable by cells. Identifying a cell's response to a known toxin, for example, could enable it to be utilised as a "canary in a coal mine" for detecting harmful compounds in acquired air samples. Biomolecules, particularly antibodies, can act as transducers because of their high specificity for complementary molecules. By combining antibodies with new Nano-scale technology, ultra-sensitive detection methods could be developed. Bio-inspired manufacturing holds promise for building Nano scale assemblies, potentially paving the way for significant breakthroughs in sensor design and materials technology.
Bioelectronics and Biosensors Market Segment Analysis:
Based on the Product, the market is segmented into Electrochemical Biosensors, Piezoelectric Biosensors, Thermal Biosensors, and Optical Biosensors. Electrochemical Biosensors segment is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. Electrochemical biosensors based on cells have made significant contributions to biology, medicine, chemistry, pharmacology, and environmental science. These biosensors, which use electrochemical transducers and entire cells as recognition elements, open up new possibilities for bio sensing and life science research. High sensitivity, remarkable precision and accuracy, ease of handling, low cost, little sample demand, simple integration into portable platforms, low power consumption, and multiplexing possibilities are just a few of the advantages of electrochemical biosensors.

Based on the End-Use, the market is segmented into Healthcare, Food & Beverage, Environmental, and Others. Healthcare segment is expected to hold the largest market share of xx% by 2029. Due to increased usage of bioelectronics in medical devices, point-of-care (POC) diagnostics, prosthetics, disease detection and monitoring, and other applications, the healthcare segment is expected to dominate the market. This is the key factor that is expected to drive the growth of the healthcare segment in the global market during the forecast period 2023-2029.
Regional Insights:
Europe region is expected to dominate the Bioelectronics and Biosensors market during the forecast period 2023-2029. Europe region is expected to hold the largest market share of xx% by 2029. Since several years, Europe has been a key centre for bioelectronics and other electronic devices. This region is expected to hold a significant market share during the forecast period due to the presence of major industry participants as well as early adoption and development of bioelectronics.

North America region is expected to grow rapidly at a CAGR of xx% during the forecast period 2023-2029. This is due to the growing demand for bioelectronics and biosensors in the Healthcare, Food & Beverage, and Environmental industries in the North America region.

The objective of the report is to present a comprehensive analysis of the Global Bioelectronics and Biosensors Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Bioelectronics and Biosensors Market dynamic, structure by analyzing the market segments and project the Global Bioelectronics and Biosensors Market size. Clear representation of competitive analysis of key players by Product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Bioelectronics and Biosensors Market make the report investor’s guide.
Bioelectronics and Biosensors Market Scope: Inquire before buying



Bioelectronics and Biosensors Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2018 to 2022
Market Size in 2022:
US $ 29.66 Bn.


Forecast Period 2023 to 2029 CAGR:
9.2%
Market Size in 2029:
US $ 54.93 Bn.


 Segments Covered:
by Product
Electrochemical Biosensors
Piezoelectric Biosensors
Thermal Biosensors
Optical Biosensors


by Application
Implantable Devices
Biochips
Fabrication Templates
Prosthetics
Artificial/Bionic Organs
Biofuel Cells
Molecular Motors
Others


by End-Use
Healthcare
Food & Beverage
Environmental
Others



Bioelectronics and Biosensors Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina and Rest of South America)
Bioelectronics and Biosensors Market Key Players are:
1. Medtronic
2. F. Hoffmann-La Roche Ltd
3. Abbott
4. Siemens Healthineers
5. Bioelectronics Corporation
6. LifeSensors
7. AgaMatrix
8. Nova Biomedical
9. Broadcom
10.Beckman Coulter
11.OmniVision Technologies, Inc.
12.Sensirion AG
13.Sotera Wireless
14.HONEYWELL INTERNATIONAL INC.
15.Universal Biosensors
16.Bayer A. G.
17.Salvia Bioelectronics
18.Printed Electronics at RISE
19.Breezing Co.
20.Centre for Organic Electronics

Frequently Asked Questions:

1] Which region is expected to hold the highest share in the Bioelectronics and Biosensors Market?
Ans. Europe is expected to hold the highest share in the Bioelectronics and Biosensors Market.

2] Who are the top key players in the Bioelectronics and Biosensors Market?
Ans. Medtronic, F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers, Bioelectronics Corporation, and LifeSensors are the top key players in the Bioelectronics and Biosensors Market.

3] Which segment holds the largest market share in the Bioelectronics and Biosensors market by 2029?
Ans. Healthcare segment hold the largest market share in the Bioelectronics and Biosensors market by 2029.

4] What is the market size of the Bioelectronics and Biosensors market by 2029?
Ans. The market size of the Bioelectronics and Biosensors market is expected to reach US $ 54.93 Bn. by 2029.

5] What was the market size of the Bioelectronics and Biosensors market in 2022?
Ans. The market size of the Bioelectronics and Biosensors market was worth US $ 29.66 Bn. in 2022.